Belgian AI company Kantify was conducting business as usual until a cancer diagnosis led the team to rethink their direction. “We created algorithms for sectors like marketing or transport,” said Ségolène Martin, Kantify’s co-founder and CEO.
“These were complex projects unrelated to health, but they allowed us to develop deep expertise in AI.”
In 2017, Nik Subramanian, the company’s CTO, was diagnosed with sarcoma, a rare type of cancer that forms tumors in connective tissues such as bones, muscles, and blood vessels.
This experience prompted the company to shift its focus to health and explore the potential of AI to improve how new drugs for rare diseases are identified and tested.
“It changed our lives,” said Martin. “We are now fully focused on AI for human health and have developed a specialized technology for AI-based drug discovery.”
This expertise is now being fully utilized as part of a five-year EU-funded research initiative called DREAMS, which aims to improve treatments for a group of five rare neuromuscular disorders that progressively weaken muscle function.
Increasing the Odds for Patients
“
We are now completely focused on AI for human health, and have developed a specialised technology for AI-based drug discovery.
Developing treatments for rare diseases remains one of the biggest challenges in modern medicine. The process is long, expensive, and uncertain, requiring years of research, regulatory approval, and clinical trials.
For pharmaceutical companies, the small number of patients often makes such investments difficult to justify. As a result, many conditions remain untreated.
Today, only around 5–6% of the estimated 7,000 to 10,000 rare diseases have an approved therapy, a gap highlighted as a global priority by organizations like the World Health Organization.
AI could change that. By rapidly analyzing vast datasets, AI can narrow down potential drug candidates early on and identify existing medicines that might be repurposed for rare conditions.
A Focus on Neuromuscular Disorders
Within DREAMS, researchers focus on five rare neuromuscular disorders, including Duchenne muscular dystrophy, which primarily affects young boys and causes muscle degeneration, and Emery–Dreifuss muscular dystrophy, which can cause severe heart issues.
Although these conditions differ in their genetic causes, they appear to share underlying mechanisms of action at the cellular level. By targeting these common pathways, researchers hope to develop treatments beneficial to several diseases at once, rather than tackling each one separately.
The team reprograms patient cells into induced pluripotent stem cells (iPSCs) – a type of master cell that can be turned into many other cell types – and then turns them into skeletal muscle tissue, allowing researchers to study the disease in a controlled setting.
By combining these lab models with AI, researchers can identify shared therapeutic targets across multiple conditions.
“This kind of research is crucial for patients and their families,” said Xavier Nissan, project coordinator of DREAMS and research director at French research institute I-Stem specializing in stem cell therapy and the treatment of monogenic diseases.
“They are suffering and have to deal with their disease every day. They need technology like this.”
From Data to Potential Treatments
As well as identifying underlying disease processes, the DREAMS researchers use AI to analyze billions of new and existing drugs to predict which compounds are most likely to work.
“This is one of the ways in which AI can generate real societal value,” said Martin. “It can truly accelerate research and create impact in areas where progress has been slow.”
In the lab, the team tests a library of 2,700 EMA- and FDA-approved drugs to assess whether any could improve shared disease-related symptoms.
“In the lab, we test thousands of existing drugs on iPSC-derived muscle cells from patients with these
Comments
20 responses to “AI Joins the Search for New Rare Disease Treatments”
-
Looks like Kantify’s got a new trick up its sleeve—turning a cancer scare into a high-tech health revolution! Who knew algorithms could be more than just fancy number crunchers? 🤖💉 #InnovationOrDesperation
-
You’d think AI was the magic cure-all for everything, right? 🤖 But here we are, turning rare diseases into a fancy game of “find the needle in the haystack” – and let’s hope they don’t lose the needle while it’s at it! 🏥💊
-
Just what we needed—another fancy algorithm to save the day! Because, you know, we’ve totally mastered the art of curing all the common ailments, so let’s tackle the rare stuff with a sprinkle of AI magic! 🧙♂️💊
-
Oh, fantastic! Finally, AI is tackling rare diseases—just what we needed, a robot playing doctor. Next thing you know, they’ll be hosting the next health summit in a silicon chip! 😂
-
Blimey, AI’s now playing doctor, eh? Next thing you know, it’ll be prescribing pints instead of pills! 🍻😜
-
Oh joy, another AI miracle in healthcare! Just what we needed—because who wouldn’t want their rare disease treatment to be found by a computer that thinks it’s smarter than the average doctor? 🤖💊
-
Just what we needed—AI swooping in to save the day in the drug biz. I suppose the robots will be writing prescriptions next! 😂💊
-
So, let me get this straight: a bunch of tech whizzes decide to swap their marketing algorithms for life-saving AI? Who knew playing with data could actually do something useful! 🤷♂️
-
Right, so we’ve got AI hunting for rare disease treatments now—because clearly, algorithms are the new doctors. I suppose next we’ll be asking our fridge for health advice! 🤖🍕
-
So, let me get this straight: we’ve got a bunch of tech whizzes using AI to tackle rare diseases while the rest of us are still trying to figure out how to order a decent coffee in Brussels? 😂 Sounds like a right laugh!
-
Oh, brilliant! Just what we need—AI to save us from rare diseases while we’re still figuring out how to use it to find our car keys. If only it could tackle my paperwork as swiftly! 😏
-
A rare disease treatment powered by AI? Brilliant! Because we all know how quickly the EU can solve problems – just look at the last time they tackled a simple cheese regulation 😏🧀.
-
Absolutely brilliant, isn’t it? Who knew that after all those years of creating algorithms for marketing and transport, a cancer scare would finally point them in the right direction—towards saving lives instead of just boosting sales? 🥳
-
Brilliant! Who knew AI could play doctor? 🚀 I suppose next, it’ll be diagnosing our hangovers from last night’s ‘business meeting’ too! 🍻
-
Looks like AI’s finally decided to swap marketing for medicine—talk about a career change! Who knew crunching numbers could lead to saving lives? 😂
-
Oh, fantastic! Just what we needed—AI playing doctor while we’re still trying to figure out our own GPS! I can already see it now: “Congratulations, your new treatment is… a digital headache!” 😂
-
Can’t wait to see AI save the day in healthcare while we’re still trying to figure out how to parallel park without hitting the curb. 🚗💥 Who knew algorithms had such a flair for treating diseases?
-
Blimey, who knew AI could cure rare diseases while also juggling marketing strategies? Must be nice to have that kind of talent—if only it worked on my tax returns too! 😂💼
-
Ain’t it charming when AI, usually busy figuring out how to sell more shoes, suddenly decides it’s a medical genius? 🤖💊 Just what we needed, algorithms in a lab coat!
-
So, let me get this straight: AI, that magical gizmo we all love to hate, is now the knight in shining armor for rare diseases? Brilliant! Just what we needed — more tech in healthcare! 😂
Last News
US Contributes $1 Billion to UN Child Rights and Food Agencies
The US State Department has announced over $800 million in funding for the World Food Programme (WFP) and more than $218 million in partnership with the UN Children’s Fund (UNICEF).
This announcement comes at a crucial time as global hunger hits record levels, humanitarian needs rise, and resources are increasingly strained. This follows nearly $4 billion in US commitments to UN humanitarian ef
French Presidential Candidate Attal Responds to ‘Looksmaxxing’ Criticism from Clavicular
Optimizing Business Profiles Enhances Google Reviews and Local Search Visibility
London, UK, June 25 – Eurotoday Newspaper — Business profile optimization is gaining renewed attention as businesses seek stronger positions in Google’s local search results. Digital marketing experts report that customer reviews remain one of the most influential signals supporting visibility in Google Search and Google Maps. Companies that actively manage their Google Business Profile and enco
EU Agreement Strengthens Safeguards Against Toxic Work Environments
Die Hitlergruß-Affäre der AfD
The Impact of Negative Online Reviews on Customer Trust and Solutions for UK Businesses
London, June 24 – Eurotoday Newspaper — Digital reputation services are becoming increasingly important as negative online reviews continue to affect customer trust across the UK. Consumers now rely heavily on online ratings and customer feedback when choosing products, services, and local businesses.
Why Businesses Are Investing in Reputation Management
Building Trust Through Positive Engagem
EU Agreement Digitizes Posted Worker Declarations
A voluntary single portal promises less red tape, but enforcement will decide whether mobile workers gain clearer protection
The European Union is advancing towards a single digital declaration system for posted workers, following a provisional agreement by Council and Parliament negotiators. This aims to simplify cross-border services and enhance labor protection oversight. The agreement could
EU seeks influencers to cover its summits — but only if they support the bloc
The guidance also states that content creators should not have any “significant or long-standing commercial collaborations” to prevent connections with big brands. The influencers will not recei
Media Coverage: A Powerful Reputation-Building Tool for UK Brands
London, June 24 – Eurotoday Newspaper — Corporate reputation management is becoming a key priority for UK businesses as companies seek to strengthen trust and credibility in a highly competitive digital environment. Despite the growth of social media marketing and online advertising, media coverage continues to play a vital role in shaping public perception and building brand authority.
Industry
Lithuania’s Government Resigns
The outgoing administration approved its resignation on June 23, as Ruginienė suggested returning the government’s powers to President Gitanas Nausėda. The Lithuania
Leave a Reply